Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | May 07, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date May 07, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
After 2026-05-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-07 · Grant · Acquired 7,500 · Balance 7,500 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Shares of Common StockSEC Table I · non-derivative | Direct | 43,302 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 43,302 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 4,360 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,360 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 7, 2026 22:09 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2026 Grant] · Derivative | 7,500 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-015699 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 20:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2023 Grant] · Derivative | 3,140 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-26-007533 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,360 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 20:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,140 | $55.75 | $175,055.00 |
DisclosureSEC source: 0001437749-26-007533 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 3,732 | $139.01 | $518,785.32 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,162 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $69.82 | $523,650.00 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2021 Grant] · Derivative | 4,010 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-25-027145 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,010 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 2,639 | $108.82 | $287,175.98 |
DisclosureSEC source: 0001437749-25-027145 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,394 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 4,010 | $71.64 | $287,276.40 |
DisclosureSEC source: 0001437749-25-027145 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2025 Grant] · Derivative | 7,500 | $0.00 Strike: $94.66 | $0.00 |
DisclosureSEC source: 0001437749-25-015814 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-05-07 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 20, 2025 Filed Feb 20, 2025 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2021 Grant] · Derivative | 1,745 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-25-004609 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,010 Underlying: Common Stock · 5,755 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 20, 2025 Filed Feb 20, 2025 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,745 | $71.64 | $125,011.80 |
DisclosureSEC source: 0001437749-25-004609 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 20:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,605 | $127.00 | $203,832.27 |
DisclosureSEC source: 0001437749-24-027024 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,278 Read SEC document |
| May 09, 2024 Filed May 13, 2024 21:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $96.03 | $0.00 |
DisclosureSEC source: 0001437749-24-016313 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-05-08 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2021 Grant] · Derivative | 1,745 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-24-005083 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,755 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,745 | $71.64 | $125,011.80 |
DisclosureSEC source: 0001437749-24-005083 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2020 Grant] · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,895 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,895 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 5,185 | $93.50 | $484,797.50 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · nonDerivative · entry 4 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 F2 · shares: Shares were withheld by the Company to pay the exercise price. F4 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $64.64 | $484,800.00 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · nonDerivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Commmon Stock | 4,912 | $93.50 | $459,272.00 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,823 F2 · shares: Shares were withheld by the Company to pay the exercise price. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 5,895 | $77.92 | $459,338.40 |
DisclosureSEC source: 0001437749-24-000878 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 20:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,550 | $68.22 | $105,741.00 |
DisclosureSEC source: 0001437749-23-024777 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,840 Read SEC document |
| May 04, 2023 Filed May 4, 2023 22:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2023 Grant] · Derivative | 7,500 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-23-012634 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | PurchaseShares of Common Stock | 2,176 | $57.45 | $125,011.20 |
DisclosureSEC source: 0001437749-23-004762 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,390 Read SEC document |
| May 11, 2022 Filed May 13, 2022 19:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-012335 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460 Underlying: Common Stock · 5,480 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2022 Filed May 13, 2022 19:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-22-012335 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 17:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011297 · rdgdoc.xml · derivative · entry 7 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2021 Filed May 7, 2021 19:52 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-21-011325 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 20:37 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-21-004977 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 20:37 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-21-004977 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-20-010063 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,605 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-20-003501 · rdgdoc.xml · derivative · entry 4 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,895 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,605 | $77.92 | $125,061.60 |
DisclosureSEC source: 0001437749-20-003501 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 21:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 3,958 | $87.35 | $345,731.30 |
DisclosureSEC source: 0001437749-20-000806 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,569 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of common shares owned following the net issuance of 1,550 shares as reported on this form. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 21:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 5,508 | $62.78 | $345,792.24 |
DisclosureSEC source: 0001437749-20-000806 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on June 2, 2016. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 15:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,714 | $84.78 | $145,312.92 |
DisclosureSEC source: 0001437749-19-016706 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,019 Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 15:49 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 919 | $79.50 | $73,060.50 |
DisclosureSEC source: 0001437749-19-011675 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,733 Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:31 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-19-009489 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,714 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-19-004616 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,786 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,714 | $72.94 | $125,019.16 |
DisclosureSEC source: 0001437749-19-004616 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,418 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-19-002638 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,418 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 2,499 | $83.75 | $209,291.25 |
DisclosureSEC source: 0001437749-19-002638 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,938 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,418 | $61.25 | $209,352.50 |
DisclosureSEC source: 0001437749-19-002638 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 16, 2019 Filed Jan 17, 2020 21:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,508 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-20-000806 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,508 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 19, 2018 22:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,877 | $80.00 | $150,160.00 |
DisclosureSEC source: 0001437749-18-021093 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,019 Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 22:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 24 | $81.40 | $1,953.60 |
DisclosureSEC source: 0001437749-18-020865 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,896 Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 9 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 8 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 7 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.